TBA (last known deadline was September 4, 2012)
The American Diabetes Association and GlaxoSmithKline Award in the Microbiome and Metabolic Changes in Diabetes and Obesity are designed to support basic, translational and clinical research proposals focusing on the relationship between the microbiome and metabolism, including the role of the microbiome in the predisposition to and progression of obesity and diabetes. Specifically, these grants would support research aimed at understanding: 1) the impact of changes in diet, lifestyle and/or therapeutics on microbiome composition and function and 2) the mechanistic pathways through which microbiome composition and function may impact host metabolic function.
Awards provide up to $375,000 over three years ($125,000 per year including indirect costs) for Basic Science projects. Translational and Clinical Research projects will receive a maximum of $750,000 over three years ($250,000 per year including indirect costs).